Foresight Group Ltd Liability Partnership lessened its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 96.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,693 shares of the real estate investment trust's stock after selling 553,640 shares during the quarter. Foresight Group Ltd Liability Partnership's holdings in Healthcare Realty Trust were worth $313,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Crossmark Global Holdings Inc. acquired a new stake in shares of Healthcare Realty Trust during the 1st quarter worth about $228,000. Golden State Wealth Management LLC acquired a new stake in Healthcare Realty Trust during the first quarter worth approximately $26,000. Oppenheimer Asset Management Inc. boosted its position in Healthcare Realty Trust by 31.4% during the first quarter. Oppenheimer Asset Management Inc. now owns 60,301 shares of the real estate investment trust's stock worth $1,019,000 after acquiring an additional 14,400 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Healthcare Realty Trust by 8.6% during the first quarter. Sequoia Financial Advisors LLC now owns 14,803 shares of the real estate investment trust's stock worth $250,000 after acquiring an additional 1,171 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Healthcare Realty Trust during the first quarter worth approximately $618,000.
Insider Activity at Healthcare Realty Trust
In related news, EVP Julie F. Wilson sold 15,000 shares of the company's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $18.00, for a total transaction of $270,000.00. Following the sale, the executive vice president directly owned 113,419 shares of the company's stock, valued at approximately $2,041,542. This represents a 11.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Thomas N. Bohjalian acquired 10,000 shares of the company's stock in a transaction that occurred on Wednesday, August 13th. The shares were acquired at an average price of $16.46 per share, for a total transaction of $164,600.00. Following the purchase, the director owned 75,520 shares of the company's stock, valued at $1,243,059.20. This trade represents a 15.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.37% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. decreased their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Thursday, June 26th. Raymond James Financial lowered Healthcare Realty Trust from a "market perform" rating to an "underperform" rating in a research note on Monday. Wells Fargo & Company raised their target price on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the stock an "underweight" rating in a research report on Wednesday, August 27th. Scotiabank raised shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and raised their target price for the stock from $18.00 to $20.00 in a research report on Friday, September 5th. Finally, BTIG Research reissued a "buy" rating and issued a $20.00 target price on shares of Healthcare Realty Trust in a research report on Wednesday, September 10th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $17.67.
Check Out Our Latest Research Report on Healthcare Realty Trust
Healthcare Realty Trust Price Performance
Healthcare Realty Trust stock traded down $0.24 during midday trading on Tuesday, hitting $17.84. 1,166,498 shares of the company were exchanged, compared to its average volume of 3,218,982. The company's fifty day moving average price is $16.79 and its 200-day moving average price is $16.00. Healthcare Realty Trust Incorporated has a fifty-two week low of $14.09 and a fifty-two week high of $18.82. The company has a market cap of $6.27 billion, a PE ratio of -15.50 and a beta of 0.94.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. The firm had revenue of $287.07 million for the quarter, compared to analyst estimates of $290.83 million. During the same quarter in the previous year, the business posted $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. On average, analysts expect that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.
Healthcare Realty Trust Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Thursday, August 14th. Healthcare Realty Trust's dividend payout ratio is -83.48%.
Healthcare Realty Trust Profile
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Featured Stories

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.